186 related articles for article (PubMed ID: 24281981)
1. Carbetocin at elective Cesarean delivery: a sequential allocation trial to determine the minimum effective dose.
Khan M; Balki M; Ahmed I; Farine D; Seaward G; Carvalho JC
Can J Anaesth; 2014 Mar; 61(3):242-8. PubMed ID: 24281981
[TBL] [Abstract][Full Text] [Related]
2. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2.
Anandakrishnan S; Balki M; Farine D; Seaward G; Carvalho JC
Can J Anaesth; 2013 Nov; 60(11):1054-60. PubMed ID: 24158878
[TBL] [Abstract][Full Text] [Related]
3. Carbetocin at Cesarean delivery for labour arrest: a sequential allocation trial to determine the effective dose.
Nguyen-Lu N; Carvalho JC; Farine D; Seaward G; Ye XY; Balki M
Can J Anaesth; 2015 Aug; 62(8):866-74. PubMed ID: 25860126
[TBL] [Abstract][Full Text] [Related]
4. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose.
Cordovani D; Balki M; Farine D; Seaward G; Carvalho JC
Can J Anaesth; 2012 Aug; 59(8):751-7. PubMed ID: 22717890
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section.
Boucher M; Horbay GL; Griffin P; Deschamps Y; Desjardins C; Schulz M; Wassenaar W
J Perinatol; 1998; 18(3):202-7. PubMed ID: 9659650
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin requirements at elective cesarean delivery: a dose-finding study.
Carvalho JC; Balki M; Kingdom J; Windrim R
Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1005-10. PubMed ID: 15516392
[TBL] [Abstract][Full Text] [Related]
7. Minimum oxytocin dose requirement after cesarean delivery for labor arrest.
Balki M; Ronayne M; Davies S; Fallah S; Kingdom J; Windrim R; Carvalho JC
Obstet Gynecol; 2006 Jan; 107(1):45-50. PubMed ID: 16394038
[TBL] [Abstract][Full Text] [Related]
8. Carbetocin at elective caesarean section: a sequential allocation trial to determine the minimum effective dose in obese women.
Drew T; Balki M; Farine D; Ye XY; Downey K; Carvalho JCA
Anaesthesia; 2020 Mar; 75(3):331-337. PubMed ID: 31867715
[TBL] [Abstract][Full Text] [Related]
9. Uterotonics in elective caesarean delivery: a randomised non-inferiority study comparing carbetocin 20 μg and 100 μg.
Tabl S; Balki M; Downey K; Tomlinson G; Farine D; Seaward G; Carvalho JCA
Anaesthesia; 2019 Feb; 74(2):190-196. PubMed ID: 30506558
[TBL] [Abstract][Full Text] [Related]
10. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery.
George RB; McKeen D; Chaplin AC; McLeod L
Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255
[TBL] [Abstract][Full Text] [Related]
11. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
Borruto F; Treisser A; Comparetto C
Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
[TBL] [Abstract][Full Text] [Related]
12. Carbetocin vs. oxytocin at elective caesarean delivery: a double-blind, randomised, controlled, non-inferiority trial of low- and high-dose regimens.
McDonagh F; Carvalho JCA; Abdulla S; Cordovani D; Downey K; Ye XY; Farine D; Morais M; Balki M
Anaesthesia; 2022 Aug; 77(8):892-900. PubMed ID: 35343585
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of carbetocin given as an intravenous bolus compared with short infusion for Caesarean section - double-blind, double-dummy, randomized controlled non-inferiority trial.
Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T
Br J Anaesth; 2017 May; 118(5):772-780. PubMed ID: 28498927
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of carbetocin applied as an intravenous bolus compared to as a short-infusion for caesarean section: study protocol for a randomised controlled trial.
Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T
Trials; 2016 Mar; 17():155. PubMed ID: 27004531
[TBL] [Abstract][Full Text] [Related]
15. Carbetocin versus oxytocin to reduce additional uterotonic use at non-elective caesarean section: a double-blind, randomised trial (.).
Whigham CA; Gorelik A; Loughnan TE; Trivedi A
J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3866-9. PubMed ID: 26940081
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery.
Elbohoty AE; Mohammed WE; Sweed M; Bahaa Eldin AM; Nabhan A; Abd-El-Maeboud KH
Int J Gynaecol Obstet; 2016 Sep; 134(3):324-8. PubMed ID: 27350226
[TBL] [Abstract][Full Text] [Related]
17. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial.
Duffield A; McKenzie C; Carvalho B; Ramachandran B; Yin V; El-Sayed YY; Riley ET; Butwick AJ
Anesth Analg; 2017 Mar; 124(3):857-862. PubMed ID: 28212181
[TBL] [Abstract][Full Text] [Related]
18. Oxytocin at elective caesarean delivery: a dose-finding study in women with obesity.
Peska E; Balki M; Maxwell C; Ye XY; Downey K; Carvalho JCA
Anaesthesia; 2021 Jul; 76(7):918-923. PubMed ID: 33227150
[TBL] [Abstract][Full Text] [Related]
19. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in obese nulliparous women undergoing emergency cesarean delivery.
El Behery MM; El Sayed GA; El Hameed AA; Soliman BS; Abdelsalam WA; Bahaa A
J Matern Fetal Neonatal Med; 2016; 29(8):1257-60. PubMed ID: 25946576
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial.
Moertl MG; Friedrich S; Kraschl J; Wadsack C; Lang U; Schlembach D
BJOG; 2011 Oct; 118(11):1349-56. PubMed ID: 21668768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
